Preparation of self-microemulsifying semi-solid matrix hard capsules of cyclosporine A;

In Vitro study of the effect of cyclosporine A,tetrandrine and their combination on the reversion of multidrug resistance in leukemia cell line;

General physiologically pharmcokinetics model of cyclosporine A;

Comparison between cyclosporine and glucocorticoid in treatment of oral lichen planus:a systematic review

Diazoxide and Cyclosporine A inhibits cultured primitive rat basal forebrain cholinergic neuron apoptosis induced by Aβ_(1-42)

OBJECTIVE To construct a population pharmacokinetic model for cyclosporine, which was constructed by NONMEM, and to adjust administration individually.

Clinical observation of cyclosporin A in treatment of severe ulcerative colitis;

Effects of combination of Genistein with Cyclosporin A on immune response of mouse lymphocytes in vitro;

Effect of cyclosporin A on sorcin gene expression and clinical effect in multiple myeloma patients;

Investigation of Drug Resistance of Monilia to Fluconazole and 5-fluocytosine and the Synergistic Effect of Fluconazole and Cyclosporin in Vitro;

Objective To investigate the clinical effect of cyclosporin A(CsA) as a reversal agent associated with classical chemotheraphy to reverse multidrug resistance(MDR) in refractory acute leukemia(RAL).

Objective To observe the therapeutic effect of TCM syndrome-typing based therapy(TCM-STBT)combined with cyclosporin on myelodysplastic syndrome(MDS)and investigate the correlation of efficacy with TCM syndrome type and MDS type.